Zhaoke Ophthalmology Limited

Zhaoke Ophthalmology Limited

6622.HK
Zhaoke Ophthalmology LimitedHK flagHong Kong Stock Exchange
2.80
HKD
+0.03
(+1.08%)
-0.47EPS
-5.96P/E
1.53BMarket Cap
Aug 20Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Xiaoyi Li
Full Time Employees
294
Sector
Healthcare
Industry
Biotechnology
Address
No. 1 Meide 3rd Road Guangzhou People's Republic of China
IPO Date
Apr 29, 2021
Website
zkoph.com
Similar Companies
Business
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.